Navigation Links
Cord Blood America Subsidiary Featured at NASCAR Sprint Cup Series Race
Date:3/4/2008

SANTA MONICA, Calif. and LAS VEGAS, March 4 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells to families nationwide and internationally, today announced its wholly owned subsidiary, RainMakers International, was featured with their logo prominent on car #49 at the Sunday, March 2, NASCAR UAW-Dodge 400 race at Las Vegas Motor Speedway. The race was featured on the FOX network.

"This is one of NASCAR's West Coast premiere races, an event racing fans look forward to all year round and which was sold out for the seventh straight year," said Matthew Schissler, Cord Blood America CEO. "RainMakers recently signed a services agreement with BAM Racing to sell advertising nationwide for the #49 race car, driven by Ken Schrader."

"We are enormously pleased to be selected for this high-profile assignment," said Mr. Schissler. "We're committed to finding sponsors to be involved with BAM Racing and NASCAR(TM) under this unique program."

The advertising being sold is a revolutionary new sponsorship program, over one year in development. The program's use of high-tech programming and patent-pending systems makes possible low-cost season-long space on the car and high-tech turnkey marketing components for those who secure sponsor space.

The marketing components include a promotional video customized for each sponsor; a sponsor promo-pack that includes a royalty free image license; a comprehensive sweepstakes campaign customized for each sponsor; a race website customized for each sponsor; four recorded messages for the advertiser's telephone "on hold" system, and the opportunity to become a primary sponsor for one race in 2008.

BAM Racing's renowned high-tech team developed numerous proprietary patent-pending systems to create a broad-based sponsorship program unmatched in NASCAR(TM). The revolutionary sponsorship program is designed to provide sponsors off-track exposure on par with sponsorships costing millions of dollars.

"This is a major milestone for RainMakers International," said Michael Malina, Director of Sales. "We are fortunate to have partnered with BAM Racing to introduce this low cost, highly effective advertising vehicle that virtually gives almost any business an entry into NASCAR sponsorship."

To learn more about the program, visit http://www.49team.com

About BAM Racing

BAM Racing was formed by Beth Ann and Tony Morgenthau in 2001 and enters its seventh season in NASCAR Nextel/Sprint Cup racing in 2008. Beth Ann Morgenthau's initials make up the name of BAM Racing.

The Morgenthaus, investment bankers from Coral Gables, Florida, specialize in positioning companies to reach their maximum potential. Their business acumen gives them a distinct advantage when it comes to providing maximum exposure for their sponsors.

About RainMakers International

RainMakers International, a wholly owned subsidiary of Cord Blood America (OTC BB: CBAI), represents the new breed of advertising agencies, focused on accountability and results-driven media placement. RainMakers provides project oriented media placement to fulfill client media demands, on radio, television, billboards, on-hold and special assignments. RainMakers is completely digitized, leveraging the latest technology to work quickly with our clients and media outlets. Visit our websites at http://www.49team.com or http://www.rainmakersintl.com.

About Cord Blood America

Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at http://www.corcell.com. For investor information, visit http://www.cordblood-america.com.

CONTACT:

Paul Knopick

E & E Communications

949/707-5365

pknopick@eandecommunications.com


'/>"/>
SOURCE Cord Blood America, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
2. Study Supports Use of GlycoMark Blood Test to Evaluate Therapy in Children with Diabetes
3. New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA
4. The International Diabetes Federation (IDF) Recommends Tighter Control of Blood Glucose Levels After Meals in People With Diabetes
5. CDC Awards NATT Funding to Improve Blood Clot Awareness
6. FDA Clears OmniWave(TM) Endovascular System for Clot Removal in Peripheral Blood Vessels
7. Cellestis Receives FDA Approval for Blood Test for Detecting Tuberculosis
8. Blood Donations in U.S. Testing Positive for Chagas Disease
9. One of Nations Oldest Blood Services Providers Turns to Sysmex America
10. ExonHit Completes a Prototype to Detect Alzheimers Disease From Blood
11. AspenBio Pharma Pursues FDA 510(k) Application Pathway for Appendicitis Blood Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... CALGARY , Dec. 7, 2016 /PRNewswire/ - Zenith Capital Corp. ... update that will be presented at the Company,s Annual and ... Meeting of Shareholders will take place on Thursday, December 15, ... Ross Glenn Hall (Room EC1040), 4825 Mount Royal Gate ... am (MST). A notice of meeting and management information circular, ...
(Date:12/7/2016)... Dec. 7, 2016  Biocom, the association for the ... below following passage of 21 st Century Cures legislation ... 30 by a 392-26 vote and in the Senate on ... attributed to Joe Panetta , president & CEO of ... give hope to millions of patients around the world. The ...
(Date:12/7/2016)... Dec. 7, 2016  Vyriad Inc. announced today the ... company,s Board of Directors. "We are delighted ... our business and develop our oncolytic viruses as the ... Stephen Russell , MD, PhD, CEO of Vyriad. ... our vision and passion for making a difference for ...
(Date:12/7/2016)... Colo. , Dec. 7, 2016  Muse bio, ... engineering technologies, today announced that Dr. Kevin Ness ... of the Board of Directors. Kevin ... who becomes the company,s Chief Science Officer as well ... Executive Director of the BioDesign Center at the RAS ...
Breaking Biology Technology:
(Date:12/5/2016)... , Dec. 5, 2016  The Office ... today published "Can CT Scans Enhance or Replace ... the potential of supporting or replacing forensic autopsies ... CT scan. In response to recommendations ... is exploring using CT scans as a potential ...
(Date:11/30/2016)... CHICAGO , Nov. 30, 2016  higi ... a new partnership initiative targeting national brands, industry ... and reward their respective audiences for taking steps ... Since its inception in 2012, higi has built ... US, impacting over 38 million people who have ...
(Date:11/28/2016)... "The biometric system market projected to ... system market is in the growth stage and is ... biometric system market is expected to be valued at ... 16.79% between 2016 and 2022. Government initiative in adoption ... rising use of biometric technology in financial institutes and ...
Breaking Biology News(10 mins):